Management of the COVID-19 health crisis: a survey in Swiss hospital pharmacies
Détails
Télécharger: GSASA20_swiss_survey_covid.pdf (260.18 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_752A3B8D7950
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Poster: résume de manière illustrée et sur une page unique les résultats d'un projet de recherche. Les résumés de poster doivent être entrés sous "Abstract" et non "Poster".
Collection
Publications
Institution
Titre
Management of the COVID-19 health crisis: a survey in Swiss hospital pharmacies
Titre de la conférence
Gesellschaft schweizerischer Amt- und Spitalapotheker (GSASA)-Kongress
Adresse
Digital, November 26-27, 2020
Statut éditorial
Publié
Date de publication
2020
Langue
anglais
Résumé
The COVID-19 pandemic has put a lot of strain on health systems in 2020. A review of the Swiss hospital pharmacies (HP) actions undertaken and challenges experienced during the first wave was performed to improve pharmaceutical management of future health crises.
An electronic survey was sent to all head of HP in Switzerland. The questionnaire was organized into eleven clusters of questions and covered many topics regarding the management of the COVID-19 crisis. Data collection was conducted from 19 May to 19 June 2020.
Analyses were performed with 43 answers (66%) out of 65 questionnaires sent. At the peak of the infection, 59% of HP reported that some of their workforce had to change jobs: from <10% of change (21% of HP) to >50% of change (3% of HP). Standard operating procedure or pandemic plan were previously available in 41% of HP. Crisis unit has been created in some HP mainly with the head pharmacist (61% of HP) and a member of the pharmaceutical logistics unit (34% of HP). Drug availability in COVID-19 wards was managed by increasing existing stocks (54% of HP) and/or creating extra storage space (51% of HP). Reserve supplies had been anticipated in 56% of HP. 51% of HP created drug lists containing COVID-19 specific treatments (83% of HP), sedatives (81% of HP), anaesthetics (77% of HP) and antibiotics (73% of HP). Remdesivir ran out of stock in 26% of HP and two drugs generated the most concern of shortages: propofol (49% of HP) and midazolam (44% of HP). In some HP, a pharmacist was present at ICU to support medical staff (24% of HP) and a pharmacy assistant was also dedicated (22% of HP) to resupply wards with drugs. Specific documents were drawn up to respond to medical and care personnel’s needs with regards to drug administration (29% of HP), drug preparation (29% of HP) and treatment choices (24% of HP). 47% of HP implemented specific hygiene measures (e.g. disinfection of surfaces and equipment). 77% of HP experimented problems procuring hand sanitizers and among them 53% manufactured it. 28% of HP introduced debriefings in teams.
HP in Switzerland have encountered many challenges related to the COVID-19 crisis and had to find solutions quickly and effectively. Major concerns have been identified, underlining the critical role of HP in such crisis. Managing and facing complex pandemic response scenarios requires a crisis management plan, communication, staff flexibility, teamwork, and collaboration. Therefore, team briefing and debriefings are more than important to establish a climate of trust.
An electronic survey was sent to all head of HP in Switzerland. The questionnaire was organized into eleven clusters of questions and covered many topics regarding the management of the COVID-19 crisis. Data collection was conducted from 19 May to 19 June 2020.
Analyses were performed with 43 answers (66%) out of 65 questionnaires sent. At the peak of the infection, 59% of HP reported that some of their workforce had to change jobs: from <10% of change (21% of HP) to >50% of change (3% of HP). Standard operating procedure or pandemic plan were previously available in 41% of HP. Crisis unit has been created in some HP mainly with the head pharmacist (61% of HP) and a member of the pharmaceutical logistics unit (34% of HP). Drug availability in COVID-19 wards was managed by increasing existing stocks (54% of HP) and/or creating extra storage space (51% of HP). Reserve supplies had been anticipated in 56% of HP. 51% of HP created drug lists containing COVID-19 specific treatments (83% of HP), sedatives (81% of HP), anaesthetics (77% of HP) and antibiotics (73% of HP). Remdesivir ran out of stock in 26% of HP and two drugs generated the most concern of shortages: propofol (49% of HP) and midazolam (44% of HP). In some HP, a pharmacist was present at ICU to support medical staff (24% of HP) and a pharmacy assistant was also dedicated (22% of HP) to resupply wards with drugs. Specific documents were drawn up to respond to medical and care personnel’s needs with regards to drug administration (29% of HP), drug preparation (29% of HP) and treatment choices (24% of HP). 47% of HP implemented specific hygiene measures (e.g. disinfection of surfaces and equipment). 77% of HP experimented problems procuring hand sanitizers and among them 53% manufactured it. 28% of HP introduced debriefings in teams.
HP in Switzerland have encountered many challenges related to the COVID-19 crisis and had to find solutions quickly and effectively. Major concerns have been identified, underlining the critical role of HP in such crisis. Managing and facing complex pandemic response scenarios requires a crisis management plan, communication, staff flexibility, teamwork, and collaboration. Therefore, team briefing and debriefings are more than important to establish a climate of trust.
Création de la notice
10/06/2021 12:50
Dernière modification de la notice
11/08/2022 22:02